Derniers articles listés par NCBI PubMed sur les maladies inflammatoires du foie et des voies biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
What is PubMed?
PubMed is the US National Library of Medicine. PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed
- Concerns regarding the AARC Study on Corticosteroid therapy for Autoimmune Hepatitis flare causing ACLF.
- Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate: A Case Report.
- Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients.
- A novel pathogenic variant of ATP-binding cassette subfamily B member 4 causing gallstones in a young adult.
- A study of regulatory effects of TLR4 and NF-κB on primary biliary cholangitis.
- Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases.
- Immunoglobulin G4-related sclerosing cholangitis: A review.
- Autoantibodies in patients with IL12 β1 receptor deficiency.
- The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
- Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis.
- Red blood cell distribution width for predicting significant liver inflammation in patients with autoimmune hepatitis.
- Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients.
- Increased Cthrc1 expression in primary biliary cholangitis.
- Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
- Amygdalin (Vitamin B17) pretreatment attenuates experimentally induced acute autoimmune hepatitis through reduction of CD4+ cell infiltration.
- Precision Medicine in Autoimmune Hepatitis.
- Precision Medicine in Primary Sclerosing Cholangitis.
- Precision medicine in primary biliary cholangitis.
- Sarcoidosis of the Intra- and Extrahepatic Bile Ducts with Concomitant Cholangitis in a Patient with Ulcerative Colitis.
- Hepatic involvement in sarcoidosis.
- Аdеmethionine in the treatment of fatigue in liver diseases: a systematic review.
- Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018).
- Management of giant cell hepatitis associated with chronic lymphocytic leukemia - a case series and review of the literature.
- Biallelic human ITCH variants causing a multisystem disease with dysmorphic features: A second report.
- Nivolumab-Induced Delayed Autoimmune Hepatitis-A Diagnostic and Therapeutic Challenge.
- Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review).
- Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines.
- Alteration of liver-infiltrated and peripheral blood double-negative T-cells in primary biliary cholangitis.
- Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989-2016.
- Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.
- [Ursodeoxycholic acid combined with bezafibrate in the treatment of refractory primary biliary cholangitis: a meta-analysis].
- [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
- Generation of Organoids from Mouse Extrahepatic Bile Ducts.
- A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease.
- False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.
- Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?
- Biochemical and Plasma Lipids Responses to Pemafibrate in Patients with Primary Biliary Cholangitis.
- Ursodeoxycholic Acid Accelerates Bile Acid Enterohepatic Circulation.
- Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review.
- Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases.
- The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers.
- Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based study.
- Editorial: tailoring mycophenolate mofetil rescue therapy for success in autoimmune hepatitis-authors' reply.
- Editorial: tailoring mycophenolate mofetil rescue therapy for success in autoimmune hepatitis.
- Activated Hepatic Stellate Cells and Portal Fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
- NAFLD in lipodystrophy.
- Biliary features in liver histology of children with autoimmune liver disease.
- Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.
- Interleukin-33/ST2-Mediated Inflammation Plays a Critical Role in the Pathogenesis and Severity of Type I Autoimmune Hepatitis.
- A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.
- [Characteristics of initial diagnosis in autoimmune liver disease: an 18-year, retrospective single-center study].
- Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature.
- Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients.
- Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry.
- Vedolizumab therapy is ineffective for primary sclerosing cholangitis in patients with inflammatory bowel disease: A GETAID multicentre cohort study.
- Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis.
- Novel treatments targeting immune-related mechanisms in primary biliary cholangitis.
- Novel treatments in primary sclerosing cholangitis.
- Magnetic Resonance Imaging in Primary Sclerosing Cholangitis-Current State and Future Directions.
- Clinical Trials in PBC Going Forward.
- Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
- Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features.
- Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
- Novel biomarkers for Primary Biliary Cholangitis to improve diagnosis and understand underlying regulatory mechanisms.
- The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice.
- Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.
- Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches.
- Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature.
- The "pruned tree" appearance of primary sclerosing cholangitis.
- NUDT15 Polymorphism Confer Increased Susceptibility to Thiopurine-Induced Leukopenia in Patients With Autoimmune Hepatitis and Related Cirrhosis.
- Slimming to the Death: Herbalife®-Associated Fatal Acute Liver Failure-Heavy Metals, Toxic Compounds, Bacterial Contaminants and Psychotropic Agents in Products Sold in India.
- Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma.
- Accuracy of the Simplified Criteria for Autoimmune Hepatitis in Children: Systematic Review and Decision Analysis.
- Identification of clinical risk factors for histological progression of primary biliary cholangitis.
- Usefulness of CCR7- PD-1+ follicular helper T cell subset frequencies in the diagnosis of autoimmune hepatitis.
- Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies.
- 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
- Proteomics in Primary Biliary Cholangitis.
- Fluorescent C-NanoDots for rapid detection of BRCA1, CFTR and MRP3 gene mutations.
- Successful percutaneous treatment of biliary stenosis after living donor liver transplantation in a child.
- Linear IgA Bullous Dermatosis: A Series of 17 Cases.
- The gut-liver axis in PSC: Are pathobionts the missing link?
- Successful Endoscopic Removal of a Biliary Stent with Stent-Stone Complex after Long-Term Migration.
- Cholestatic pruritus: Emerging mechanisms and therapeutics.
- The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
- [An unusual cause of jaundice].
- Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
- Acute-onset Autoimmune Hepatitis in a Patient with Selective Immunoglobulin M Deficiency.
- Outcome of Liver Transplant Patients With Intraoperative-Detected Portal Vein Thrombosis: A Retrospective Cohort Study in Shiraz, Iran.
- IgG4 Sclerosing Cholangitis - an Inflammation Imitating Tumour of the Pancreas and Biliary Tract.
- Update on primary sclerosing cholangitis.
- Novel treatments targeting metabolic and signaling mechanisms in primary biliary cholangitis.
- Recurrence of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis after transplantation.
- Malignancy in primary sclerosing cholangitis: Bile duct, liver, and colon.
- Endoscopic management of primary sclerosing cholangitis.
- Medical management of primary sclerosing cholangitis.
- Treatment of autoimmune hepatitis.
- Clinical presentation and natural history of autoimmune hepatitis.
- Autoimmune hepatitis in childhood.
- Primary sclerosing cholangitis during childhood and adolescence.
- Primary sclerosing cholangitis: Unique aspects of disease in children.
- Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.
- High frequency of concomitant food allergy development and autoantibody formation in children who have undergone liver transplantation.
- Cholangiocyte-derived exosomal LncRNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis.
- The Role of Next Generation Sequencing in the Differential Diagnosis of Caroli's Syndrome.
- Steroid free treatment in autoimmune hepatitis: Is azathioprine monotherapy truly a viable option to obtain remission?
- Ursodeoxycholic Acid Therapy and Liver Transplant-free Survival in Patients with Primary Biliary Cholangitis.
- Florid biliary duct lesions in an AMA -positive patient in absence of cholestatic liver biochemistry.
- Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels.
- Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.
- Emerging novel treatments for autoimmune liver diseases.
- Jaundice and anaemia as presenting features of an incomplete autoimmune polyglandular syndrome type II.
- Duck circovirus induces a new pathogenetic characteristic, primary sclerosing cholangitis.
- Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients.
- Secondary sclerosing cholangitis in critically ill patients.
- Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case.
- Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.
- Rheumatologic Diseases and the Liver.
- Hepatic Complications of Inflammatory Bowel Disease.
- Expression and significance of Th17 cells and related factors in patients with autoimmune hepatitis.
- Autoimmune Hepatitis and Stellate Cells; an Insight into the Role of Autophagy.
- Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases.
- Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study.
- Checkpoint Inhibitors.
- An increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan.
- Current and Promising Therapy for Primary Biliary Cholangitis.
- Metabolomics profiling in a mouse model reveals protective effect of Sancao granule on Con A-Induced liver injury.
- Development and validation of a new simplified diagnostic scoring system for pediatric autoimmune hepatitis.
- Lights And Shadows On Fibrates As Second-Line Therapy of Primary Biliary Cholangitis.
- Development of autoimmune hepatitis after influenza vaccination; trigger or killer?
- Minimally invasive assessment of hepatic function in children with indocyanine green elimination: a validation study.
- Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.
- Long-term outcomes with obeticholic acid in primary biliary cholangitis: reassuring, but still an itch we need to scratch.
- Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review.
- Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.
- Letter: vitamin D deficiency and autoimmune hepatitis - from research to treatment.
- Letter: vitamin D deficiency and autoimmune hepatitis - from research to treatment-authors' reply.
- Comparison of Sertraline with Rifampin in the treatment of Cholestatic pruritus: A randomized clinical trial.
- Pruritus Secondary to Primary Biliary Cholangitis: A Review of the Pathophysiology and Management with Phototherapy.
- [A Resected Case of Reactive Lymphoid Hyperplasia of the Liver Preoperatively Diagnosed as Hepatocellular Carcinoma].
- Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis.
- Ductular reaction in acute onset autoimmune hepatitis.
- Acute severe autoimmune hepatitis - Corticosteroids or liver transplantation?
- Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
- A case of severe rhabdomyolysis associated with secondary adrenal insufficiency and autoimmune hepatitis.
- Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus.
- A C21-Steroidal Glycoside from Cynanchum atratum Attenuates Concanavalin A-Induced Liver Injury in Mice.
- Immunological abnormalities in patients with primary biliary cholangitis.
- Cholestatic pruritus : an update.
- Are High-dose Steroids Really Necessary in Treatment of Autoimmune Hepatitis?
- Bile ductular reactions in the liver: similarities are only skin deep.
- Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model.
- Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images?
- Unusually Low Serum Alkaline Phosphatase Activity in a Patient with Acute on Chronic Liver Failure and Hemolysis.
- Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.
- Use of Fenofibrate for patients with primary Sclerosing Cholangitis.
- Recurrence of primary biliary cholangitis after liver transplantation: Is Tacrolimus really worse than other drugs?
- Liver Transplant After Normothermic Regional Perfusion From Controlled Donors After Circulatory Death: The Norwegian Experience.
- Magnetic Resonance Elastography in Primary Sclerosing Cholangitis: Interobserver Agreement for Liver Stiffness Measurement with Manual and Automated Methods.
- Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.
- [Immune-mediated cholangiopathies : Diagnostic and therapeutic challenges].
- Reply (to LTE HEP-19-0138).
- Letter to Editor: Flare of Autoimmune Hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy.
- Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
- Letter: severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis-offender or bystander? Authors' reply.
- Letter: severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis-offender or bystander?
- Endoscopic retrograde cholangiopancreatography (ERCP): lessons learned from population-based national registries: a systematic review.
- Secondary Hemophagocytic Lymphohistiocytosis: A Challenging Diagnosis in a Patient with Autoimmune Hepatitis.
- A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis.
- Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States.
- Benign biliary strictures: prevalence, impact, and management strategies.
- Identification of key challenges in liver pathology: data from a multicenter study of extramural consults.
- Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease.
- Genome Wide Association Studies of Specific Antinuclear Autoantibody Sub-phenotypes in Primary Biliary Cholangitis.
- Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
- Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland.
- Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis.
- Role of Transplant in Biliary Disease.
- Autoimmune Diseases of the Biliary Tract: A Review.
- Focal Nodular Hyperplasia Mimicked Hepatocellular Carcinoma in an Autoimmune Hepatitis Patient With Regression of Cirrhosis.
- Obeticholic acid in primary biliary cholangitis: where we stand.
- Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis.
- Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence.
- Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
- Long-term Clinical Outcomes in Patients with Autoimmune Hepatitis according to Treatment Response in Asian country.
- Molecular Pathogenesis of Cholangiocarcinoma.
- Inflammation and Neoplasia of the Pouch in Inflammatory Bowel Disease.
- Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.
- Multiple Skin Abscesses Caused by Rhizopus sp. Infection after Candida albicans Infection in an Immunocompromised Patient.
- Eradication of Helicobacter pylori in a Living Donor Liver Transplant Recipient With Immunosuppressive Therapy of Cyclosporine A: A Case Report.
- What is the Optimal Dose of Predniso(lo)ne for Induction of Remission in Patients With Autoimmune Hepatitis?
- Prevalence of autoimmune diseases and clinical significance of autoantibody profile: data from National Institute of Hygiene in Rabat, Morocco.
- Liver stiffness measurement by acoustic radiation forced impulse and transient elastography in patients with intrahepatic cholestasis.
- Racial Disparities in Presentation and Outcomes of Pediatric Autoimmune Hepatitis.
- Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients.
- Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.
- Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment.
- Role of endoscopy in the management of primary sclerosing cholangitis.
- Liver sinusoidal endothelial cells in morphogenesis of pediatric autoimmune hepatitis. Ultrastructural characteristics - a novel report.